What Happened?
Burlingame, CA-based Apexigen,-Inc Appointed Xiaodong Yang as President and Chief Executive Officer
About the Company
Apexigen, Inc. is a privately held biopharmaceutical company discovering and developing innovative antibody therapeutics for the treatment of life-threatening and difficult-to-treat diseases. Using its proprietary antibody technology platform, Apexigen has discovered a pipeline of product candidates, which are currently at varying stages of development. The lead product candidate, APX005M, is a novel immuno-oncology antibody that stimulates and enhances an immune response against cancer. Apexigen is developing other product candidates in partnership with four leading biopharmaceutical companies in China. In addition, Apexigen has formed strategic partnerships with multi-national pharmaceutical companies, including Janssen Biotech, Alcon Laboratories and Toray Industries to discover first-in-class antibody lead candidates for the partners' programs.
About the Person
Xiaodong Yang is President and Chief Executive Officer at Apexigen, Inc. Previously, Xiaodong held various senior HR leadership roles in the industry.
Info Source
News
Short Profile